Valeritas (NSDQ:VLRX) said this week that it plans to offer 37,593,984 shares of its common stock, hoping to raise $50 million in gross proceeds.
The medical technology company also announced its preliminary financial results this week for the third quarter of 2018.
Get the full story at our sister site, Drug Delivery Business News.
The post Valeritas aims for $50m in stock offering appeared first on MassDevice.